Explore the latest in PCI, including evolving indications, technologies, and use of antiplatelet agents to maximize efficacy and safety.
This pooled analysis includes data from 4 major randomized clinical trials that compare PCI with drug-eluting stents vs CABG to assess differences in outcomes for patients with left main coronary artery disease with and without acute coronary syndrome.
This randomized clinical trial compares the rate of main composite outcome of cardiac death, myocardial infarction, or ischemia-driven target lesion revascularization at 5 years in patients with acute coronary syndromes.
This cohort study uses national claims data to describe platelet ADP P2Y12 receptor inhibitor choice and switching among patients who underwent percutaneous coronary intervention for acute coronary syndrome.
This secondary analysis of the HOST-EXAM randomized clinical trial evaluates clopidogrel vs aspirin for long-term maintenance after percutaneous coronary intervention in patients with diabetes.
A man in his late 50s had reduced left ventricle systolic function and hypokinesia of the anteroseptal, anterior, anterolateral, and septal walls. Lung ultrasound demonstrated multiple B-lines in both lung fields. What would you do next?
This serial cross-sectional cohort study compares whether treatment patterns and outcomes for patients presenting with acute myocardial infarction differ for low- vs high-income individuals across 6 countries.
This case report describes a 70-year-old patient with intermittent chest pain that developed into constant chest pain, sweating, and shortness of breath.
This Viewpoint discusses whether or not the evidence cited in the 2021 American College of Cardiology/American Heart Association/Society for Cardiovascular Angiography & Interventions guidelines for coronary artery revascularization support downgrading coronary artery bypass grafting relative to medical therapy.
This comparative effectiveness study examines the types and usage rates of nonemergency cardiovascular procedures in patients with basic insurance compared with private supplementary insurance.
This cohort study evaluates the association of depression with 12-month adherence to guideline-directed medical therapies following percutaneous coronary intervention (PCI).
This randomized clinical trial determines whether routinely using ultrasonography guidance for femoral arterial access for coronary angiography/intervention reduces bleeding or vascular complications.
This 3-year follow-up of a randomized clinical trial assesses the long-term safety and efficacy of P2Y12 inhibitor monotherapy following 3 months of dual antiplatelet therapy after percutaneous coronary intervention.
This secondary analysis of a randomized clinical trial determines whether complete revascularization improves angina status in patients with ST-segment elevation myocardial infarction (STEMI) and multivessel coronary artery disease.
This cross-sectional study evaluates metrics and outcomes among patients with ST-elevation myocardial infarction in urban and rural settings in the US.
This systematic review and meta-analysis examines clinical outcomes associated with low fractional flow reserve measures after percutaneous coronary interventions with drug-eluting stents.
Customize your JAMA Network experience by selecting one or more topics from the list below.